Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders -A retrospective tolerability and safety study

被引：0
|
作者：
Iser, C. [1 ]
Anderson, C. [1 ]
Hirte, I [1 ]
Boddu, S. [1 ]
Girardo, M. [1 ]
Joseph, A. [1 ]
VanderPluym, J. [1 ]
Starling, A. [1 ]
机构：
[1] Mayo Clin, Scottsdale, AZ USA
来源：
HEADACHE | 2023年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-177
引用
收藏
页码：31 / 32
页数：2
相关论文
共 50 条
  • [21] OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT
    SK Aurora
    DW Dodick
    RE DeGryse
    CC Turkel
    The Journal of Headache and Pain, 2013, 14
  • [22] Effectiveness and Safety of Eptinezumab in Episodic and Chronic Migraine Headache in the UAE: A Retrospective Study
    Bader, Yazan
    Suliman, Reem
    Harb, Mohamad
    Santos, Vanessa
    Al Qaisi, Ibrahim
    Alsaadi, Taoufik
    NEUROLOGY AND THERAPY, 2023, 12 (05) : 1683 - 1693
  • [23] OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT
    Aurora, S. K.
    Dodick, D. W.
    DeGryse, R. E.
    Turkel, C. C.
    JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [24] Effectiveness and Safety of Eptinezumab in Episodic and Chronic Migraine Headache in the UAE: A Retrospective Study
    Yazan Bader
    Reem Suliman
    Mohamad Harb
    Vanessa Santos
    Ibrahim Al Qaisi
    Taoufik Alsaadi
    Neurology and Therapy, 2023, 12 : 1683 - 1693
  • [25] Efficacy and safety of ultrasound-guided peripheral nerve blocks in management of chronic resistant migraine
    Nourhan Abdelmohsen Taha
    Mai Fathy
    Ahmed Elsadek
    Tamer Hussein Emara
    Sherien Mohamed Farag
    Ramez Reda Moustafa
    Mohamad Osama Abdulghani
    The Journal of Headache and Pain, 26 (1)
  • [26] Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine
    Andrew M. Blumenfeld
    Sheena K. Aurora
    Karen Laranjo
    Spyros Papapetropoulos
    BMC Neurology, 15
  • [27] Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine
    Blumenfeld, Andrew M.
    Aurora, Sheena K.
    Laranjo, Karen
    Papapetropoulos, Spyros
    BMC NEUROLOGY, 2015, 15
  • [28] Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe
    Matharu, Manjit
    Pascual, Julio
    Nilsson Remahl, Ingela
    Straube, Andreas
    Lum, Arlene
    Davar, Gudarz
    Odom, Dawn
    Bennett, Lee
    Proctor, Christina
    Gutierrez, Lia
    Andrews, Elizabeth
    Johannes, Catherine
    CEPHALALGIA, 2017, 37 (14) : 1384 - 1397
  • [29] Rationale for Study and Design of COMPEL: An Open-Label, Multicenter Study of the Long-Term Efficacy, Safety, and Tolerability of OnabotulinumtoxinA for Headache Prophylaxis in Adults with Chronic Migraine
    Blumenfeld, A. M.
    Aurora, S. K.
    Laranjo, K.
    Varon, S. F.
    Papapetropoulos, S.
    HEADACHE, 2012, 52 (05): : 881 - 881
  • [30] Efficacy, tolerability, and safety of onabotulinumtoxinA treatment for chronic migraine in patients with acute medication overuse: analysis of the PREEMPT and COMPEL trials
    Agosti, R.
    Straube, A.
    Diener, H. C.
    Freeman, M.
    Pascual Gomez, J.
    Seminerio, M.
    Delahaye, L.
    Stark, R. J.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
12345